FRC
FRC Logo
Community
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • Community
  • FAQ
  • How to use the site

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Markets

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Strategies
Intel
Analysis
Community
Company ProfileMedical Developments International Limited
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
MVP.AX
Medical Developments International Limited Stock AnalysisComprehensive stock analysis for Medical Developments International Limited (MVP.AX) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisMVP.AX
MVP.AX
Medical Developments International Limited
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
MVP.AX
  1. Home
  2. Stocks
  3. Medical Developments International Limited

Medical Developments International Limited

🇦🇺MVP.AX•ASX

Medical Developments International Limited

🇦🇺MVP.AX•ASX
P/E ratio
75.89

Your view on MVP.AX

P/E
75.89
Your view
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Medical Developments International Limited

Industry
Drug Manufacturers - Specialty & Generic
Sector
Healthcare
CEO
Brent MacGregor
Headquarters
4 Caribbean Drive, Scoresby, VIC, AU
Industry
Drug Manufacturers - Specialty & Generic
Sector
Healthcare
CEO
Brent MacGregor
Headquarters
4 Caribbean Drive, Scoresby, VIC, AU
Description

Medical Developments International Limited (MDIL) specializes in the development and provision of essential emergency medical solutions, serving global markets including Australia, Europe, and the United States. The company's operations are divided into two primary segments: Pain Management and Respiratory care.

Among its key offerings is Penthrox, a product specifically formulated for rapid pain relief in acute trauma and emergency situations. Within the respiratory segment, MDIL supplies equipment designed to assist individuals with conditions like asthma and chronic obstructive pulmonary disease (COPD).

Additionally, its comprehensive portfolio features a diverse array of medical devices, encompassing items such as CPR face shields and masks, finger pulse oximeters, flow meter regulators, MDI tourniquets, manually triggered ventilators, oxygen resuscitation kits, and various oxygen therapy and resuscitation apparatus.

Established in 2003, the company maintains its headquarters in Scoresby, Australia.

Financial Data

Stock Data

Price chart, volume, and trading data.

FRC Fair Value Algorithm

What the FRC Fair Value algorithm says it is worth vs. the current price — FRC's own, on every stock.

About this section

Fair value for Medical Developments International Limited from FRC's valuation model, read against the market price. MVP.AX last traded at AUD 0.49, 75.9× trailing earnings — the estimate is read against that market price. The model runs on every stock on the platform and shows the estimate per share and the date it was calculated. A free account covers 3 company valuations a month; a paid subscription is unlimited.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

About this section

Valuation, profitability, liquidity and leverage ratios for Medical Developments International Limited. Starting points for Medical Developments International Limited: P/E 75.9, EPS AUD 0.0056, beta 1.39 — an Drug Manufacturers - Specialty & Generic name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

About this section

Dividend history, yield and payout sustainability for Medical Developments International Limited. Medical Developments International Limited does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

About this section

Reported vs. expected earnings history for Medical Developments International Limited. Trailing twelve-month EPS for Medical Developments International Limited stands at AUD 0.0056. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Wall Street Analyst Estimates

Analysts' price targets, ratings, and revenue and EPS estimates.

Wall Street analysts· not FRC research
Nov 20, 2026
More →

Earnings per share estimates

Per shareThis quarterSep 2025Next quarterDec 2025This yearYear to Jun 2027Next yearYear to Jun 2028
Average estimateAUD 0.00−AUD 0.01AUD 0.01AUD 0.04
Lowest estimateAUD 0.00−AUD 0.01−AUD 0.00AUD 0.02
Highest estimateAUD 0.00−AUD 0.01AUD 0.03AUD 0.05
Number of analysts0122
A year ago−AUD 0.071−AUD 0.10AUD 0.011—
Growth vs a year ago—+86.0%——

1The year-ago figure includes one-time items, so growth is not shown.

Revenue estimates

TotalThis quarterSep 2025Next quarterDec 2025This yearYear to Jun 2027Next yearYear to Jun 2028
Average estimateAUD 19.69MAUD 21.60MAUD 45.95MAUD 51.30M
Lowest estimateAUD 19.69MAUD 21.60MAUD 45.70MAUD 51.20M
Highest estimateAUD 19.69MAUD 21.60MAUD 46.20MAUD 51.40M
Number of analysts1122
A year agoAUD 12.77MAUD 18.41MAUD 42.57M—
Growth vs a year ago+54.2%+17.3%+7.9%—

Financial Statements

Income statement, balance sheet, and cash flow statements.

About this section

Income statement, balance sheet and cash flow history for Medical Developments International Limited. Medical Developments International Limited has reported as a listed company since 2003. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

Peers, the industry, and the funds that hold MVP.AX19 companies
Compare MVP.AX with its peers, side by sidePremiumRatios, margins, valuation and leverage of the peers below — one table, one glance.Open Comparable Analysis
Peer companies
TickerTypeCompanySectorIndustry
ATX.AXAmplia Therapeutics LimitedHealthcareBiotechnology—
CYC.AXCyclopharm LimitedHealthcareMedical - Devices—
GSS.AXGenetic Signatures LimitedHealthcareMedical - Diagnostics & Research—
IPD.AXImpediMed LimitedHealthcareMedical - Devices—
M7T.AXMach7 Technologies LimitedHealthcareMedical - Healthcare Information Services—
MX1.AXMicro-X LimitedHealthcareMedical - Devices—
PCK.AXPainChek LimitedHealthcareMedical - Healthcare Information Services—
More Drug Manufacturers - Specialty & Generic companies
TickerTypeCompanySectorExchangeMkt cap
APTX.TOApotex Health Corp.HealthcareTSX$9.4B
AQSTAquestive Therapeutics, Inc.HealthcareNASDAQ$475.1M
AQSZFAequus Pharmaceuticals Inc.HealthcareOTC$652,561
ARSUFFagron N.V.HealthcareOTC$2.0B
ARYXARYx Therapeutics, Inc.HealthcareOTC$16,731
AUSAFAustralis Capital Inc.HealthcareOTC$27,828
AVCN.TOAvicanna Inc.HealthcareTSX$11.8M
AVCNFAvicanna Inc.HealthcareOTC$16.3M
AVNT.TOAvant Brands Inc.HealthcareTSX$8.0M
AVTBFAvant Brands Inc.HealthcareOTC$6.9M
AXRXAmexdrug CorporationHealthcareOTC$33,882
AYRWFAyr Wellness Inc.HealthcareOTC$2.6M
Open Comparable Analysis
Ownership & News

News

Latest headlines and market coverage.

About this section

Latest headlines and company announcements for Medical Developments International Limited. Coverage tracks Medical Developments International Limited within Drug Manufacturers - Specialty & Generic (Healthcare). Press releases and market coverage, newest first.

Discussion

Comments

Comments and replies from FRC members about this company.

No comments yet

Be the first to ask a question or say what you make of Medical Developments International Limited.

MVP.AX AnalysisWeak
Past
1
Growth
1
Health
5
Profit
1
Value
1